Traditional Chinese medicine decoction and treatment method for treating cerebral thrombosis by needle-medicine combination

Abstract

The invention discloses a traditional Chinese medicine decoction and treatment method for treating cerebral thrombosis through needle-medicine combination. The treatment method comprises the followingoperation steps: S1, preparing a reconstitution prescription; S2, performing acupuncture treatment; S3, performing fumigation treatment; S4, performing balanced application; S5, dredging channels andcollaterals; S6, carrying out a blood pricking therapy; and S7, performing autologous blood transfusion. According to the traditional Chinese medicine decoction and treatment method for treating cerebral thrombosis through needle-medicine combination, a traditional Chinese medicine decoction oral therapy is matched for achieving the effects of conditioning the environment in human bodies and enhancing the immunity enhancing effect. The traditional Chinese medicine decoction is matched with a seven-step therapy to enrich blood and nourish qi, induce resuscitation, restore consciousness, dredgechannels and collaterals and improve the immunity of a patient. The traditional Chinese medicine decoction solves the problems that thrombus dissolving medicines, such as aspirin or NIKKEN nattokinase and urokinase, which need to be taken for a long time are in the traditional western medicine therapy, are emergency thrombolytic injection medicines and have large side effects, short thrombus dissolving time, no thrombus dissolution and easiness in relapse.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine decoction and a treatment method for treating cerebral thrombosis in combination with acupuncture and medicine. Background technique [0002] Cerebral thrombosis is the most common type of cerebral infarction. It is the thickening of blood vessels, stenosis and occlusion of the lumen caused by atherosclerosis of the cerebral artery trunk or cortical branches, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and ischemia. Oxygen leads to softening necrosis and focal nervous system symptoms. Compared with cerebral hemorrhage, the fatality rate of thrombosis is lower and the disability rate is higher. The fatality rate increases significantly with age. The average fatality rate is about 25%. Survivors with organ failure, secondary infection, and cardiopulmonary insufficiency have a high...

AI Technical Summary

Problems solved by technology

[0002] Cerebral thrombosis is the most common type of cerebral infarction. It is the thickening of blood vessels, stenosis and occlusion of the lumen caused by atherosclerosis of the cerebral artery trunk or cortical branches, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and ischemia. Oxygen leads to softening necrosis and focal nervous system symptoms. Compared with cerebral hemorrhage, the fatality rate of thrombosis is lower and the disability rate is higher. The fatality rate increases significantly with age. The average fatality rate is about 25%. Survivors with organ failure, secondary infection, and cardiopulmonary insufficiency have a higher disability rate. About 20% of survivors relapse within 1 to 2 years. Drugs should be taken under the guidance of professional doctors. The treatment of cerebral thrombosis should be determined according to the patient's condition. If it is in the acute stage, thrombolytic therapy should be taken within four to five hours after the onset of the disease to control the patient's blood pressure, blood sugar, Blood lipids and other indicators, anticoagulation, anti-platelet aggregation, and lowering intracranial pressure should be treated at the same time to prevent the progression of the disease. If it is in the chronic phase, rational medication should be used, such as anti-platelet aggregation, statins and other drugs to prevent repeated cerebral thrombosis. Attack, but long-term use of thrombolytic drugs, such as aspirin or Nikken nattokinase, urokinase are emergency thrombolytic injection drugs, side effects are large, the time to dissolve the thrombus is short, the thrombus does not dissolve, and it will recur. In view of this , with in-depth research on the above problems, this case arises